Eli Lilly (LLY) Acquires Psychedelic Drug Developer AtaiBeckley in $2.8B Deal
Key Highlights Pharmaceutical giant Eli Lilly is purchasing psychedelic therapy company AtaiBeckley in a transaction valued at $2.8 billion cash upfront, potentially reaching $3.8 billion wit




